Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study
British Journal of Surgery · 02.09.2025 · 112 (9)
DOI: 10.1093/bjs/znaf180 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Surgery, online erschienen am 18.09.2025. Verfasst von Thorsten Kühn und 49 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynaecology and Obstetrics, University of Ulm, Ulm, Germany. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoadjuvant Therapy, Lymph Node Excision. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: AGO Breast Study Group, Claudia von Schilling Foundation, Ehmann Foundation Savognin.
Abstract (Originalsprache)
Background
Completion axillary lymph node dissection (cALND) is often recommended for patients with isolated tumour cells (ITCs) or micrometastases in the sentinel lymph node (SLN) or target lymph node (TLN) to assess the definite nodal tumour burden after neoadjuvant chemotherapy (NACT). The aim of this study was to investigate the upgrade of N stage by cALND in patients with low-volume metastases in the SLN/TLN after NACT from the prospective, international, multicentre AXSANA cohort study.
Methods
NACT-treated patients that converted from a positive to a negative clinical lymph node status and underwent cALND based on low-volume SLN/TLN involvement were included. The association between the final N stage, the pathological tumour response in the breast, and the clinical impact of cALND on post-NACT treatment decisions was determined.
Results
Among 5329 patients recruited between June 2020 and March 2024, 2194 were scheduled for SLN biopsy (SLNB), targeted axillary dissection (TAD), or TLN biopsy (TLNB). Among 16 patients with ypN0i+(SLN/TLN), one patient was upgraded to ypN1a by cALND, while five of the 71 patients with ypN1mi(SLN/TLN) were upstaged to ypN2 and one of the 71 patients with ypN1mi(SLN/TLN) was upstaged to ypN3. None of these patients had a pCR in the breast and thus nodal upstaging had no impact on post-NACT treatment decisions.
Conclusion
Despite substantial additional nodal involvement in low-volume SLN/TLN disease, cALND does not provide clinically meaningful information for post-NACT systemic treatment modifications and should not be encouraged for diagnostic purposes alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gynaecology and Obstetrics, University of Ulm, Ulm, Germany.
- Breast Centre, Die Filderklinik gGmbH, Filderstadt, Germany.
- Department of Obstetrics and Gynaecology, University Hospital of Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
- Department of Gynaecology and Obstetrics, University Hospital Augsburg, Augsburg, Germany.
- Department of Gynaecology and Obstetrics, University Hospital Aachen, Aachen, Germany.
- Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
ORCID-Profile: Thorsten Kühn, Michael Hauptmann, Hans-Christian Kolberg, Isabel Teresa Rubio, Maria Luisa Gasparri, Eduard-Alexandru Bonci, Laura Niinikoski, Ashutosh Kothari, Oreste Davide Gentilini, Jana de Boniface
Förderung
- AGO Breast Study Group
- Claudia von Schilling Foundation
- Ehmann Foundation Savognin
- Eugen and Irmgard Hahn Foundation
Zitieren
APA
Kühn, T., Banys-Paluchowski, M., Ditsch, N., Stickeler, E., Hauptmann, M., Schroth, J., Karadeniz Cakmak, G., Hahn, M., Thill, M., Reimer, T., Fröhlich, S., Schmidt, E., Wihlfahrt, K., Berger, T., Basali, T., Ruf, F., Rief, A., Lux, M. P., Kolberg, H. C., …, & AXSANA Study Group (2025). Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study. British Journal of Surgery, 112(9). https://doi.org/10.1093/bjs/znaf180
Vancouver
Kühn T, Banys-Paluchowski M, Ditsch N, Stickeler E, Hauptmann M, Schroth J, et al. Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study. British Journal of Surgery. 2025;112(9). doi:10.1093/bjs/znaf180
BibTeX
@article{Khn2025,
author = {Kühn, Thorsten and Banys-Paluchowski, Maggie and Ditsch, Nina and Stickeler, Elmar and Hauptmann, Michael and Schroth, Jennifer and Karadeniz Cakmak, Guldeniz and Hahn, Markus and Thill, Marc and Reimer, Toralf and Fröhlich, Sarah and Schmidt, Esther and Wihlfahrt, Kristina and Berger, Tomasz and Basali, Timo and Ruf, Franziska and Rief, Angelika and Lux, Michael Patrick and Kolberg, Hans-Christian and Rubio, Isabel Teresa and Gasparri, Maria Luisa and Kontos, Michalis and Bonci, Eduard-Alexandru and Niinikoski, Laura and Murawa, Dawid and Pinto, David and Peintinger, Florentia and Schlichting, Ellen and Nina, Helidon and Valiyeva Qanimat, Hagigat and Vanhoeij, Marian and Rebaza, Lia Pamela and Aktas Sezen, Bilge and Jursik, Katharina and Kadayaprath, Geeta and Dostalek, Lukas and Kothari, Ashutosh and Perhavec, Andraz and Ivanov, Tsvetomir and Zippel, Douglas and Thongvitokomarn, Sarun and Gurleyik, Meryem Gunay and Watermann, Dirk and Porpiglia, Mauro and Lebeau, Annette and Di Micco, Rosa and Gentilini, Oreste Davide and de Boniface, Jana and Hartmann, Steffi and AXSANA Study Group, AXSANA Study Group},
title = {Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study},
journal = {British Journal of Surgery},
year = {2025},
volume = {112},
number = {9},
doi = {10.1093/bjs/znaf180}
}
EUVIMED